The National Bleeding Disorders Foundation (NBDF) will be leading efforts this March — during Bleeding Disorders Awareness Month, simply called BDAM — to provide…
Von Willebrand disease
A real-world study has found that during hospitalizations among people with von Willebrand disease (VWD), VWF replacement therapy with lab-made Veyvondi (vonicog alfa) is…
Preventive (prophylactic) treatment with Wilate reduced annual bleeding rates by more than 80% in people with von Willebrand disease (VWD) type 3, the…
HMB-002, an antibody-based experimental treatment for von Willebrand disease (VWD) currently in early clinical testing, boosted levels of the protein whose deficiency causes VWD,…
The many types of von Willebrand disease may be much more common globally than previously thought, a large study of more than 800,000 people…
Scientists have developed a gene-editing therapy to selectively disable the genetic mutations responsible for Von Willebrand disease (VWD) type 2, regardless of subtype, potentially…
Von Willebrand disease (VWD) harms physical and mental health-related quality of life, with an increased burden for women and those with severe disease types,…
The shape of the ADAMTS13 enzyme during remission (a period when symptoms ease or disappear) may help predict which people with immune-mediated thrombotic thrombocytopenic…
A recent case report highlights the challenges of performing surgery in a patient with more than one bleeding disorder. Two doctors in Portugal described their…
People with von Willebrand disease (VWD) or hemophilia A are more likely to experience serious bleeding in the first month after a kidney transplant, a…
